Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 1 , Pages 16-22, January 2008

Low-dose of Statin Treatment Improves Cerebrovascular Reactivity in Patients With Ischemic Stroke: Single Photon Emission Computed Tomography Analysis

  • Masaji Murakami, MD, PhD

      Affiliations

    • Department of Neurosurgery, Kumamoto Takumadai Hospital, Kumamoto, Japan
    • Corresponding Author InformationAddress correspondence to Masaji Murakami, MD, PhD, Department of Neurosurgery, Kumamoto Takumadai Hospital, Onoue 1-14-27, Kumamoto 862-0913, Japan.
  • ,
  • Shodo Fujioka, MD, PhD

      Affiliations

    • Department of Neurosurgery, Saiseikai Kumamoto Hospital, Kumamoto, Japan
  • ,
  • Yoshifumi Hirata, MD, PhD

      Affiliations

    • Department of Neurosurgery, Kumamoto Takumadai Hospital, Kumamoto, Japan
  • ,
  • Jun-ichi Kuratsu, MD, PhD

      Affiliations

    • Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Received 27 December 2006; accepted 3 September 2007.

Background

Statins, 3-hydroxy-3-methylglutaryl-coenzymeA reductase inhibitors, have pleiotropic effects that are independent of their cholesterol-lowering activities. For example, they improve vascular endothelial function and exert anti-inflammatory effects. In large clinical trials they reduced the incidence of stroke and myocardial infarction; however, little is currently known regarding the mechanism or mechanisms underlying their clinically confirmed stroke protection.

Patients and Methods

We assessed 10 patients who had experienced a stroke at least 6 months earlier; they received low-dose (5 mg) simvastatin. Using our triple-injection technetium 99m-ethylcysteinate dimer method, we determined their cerebral blood flow and cerebrovascular reactivity. A second assessment of at-rest cerebral blood flow and cerebrovascular reactivity was performed 4 or more months (mean 6 months) after the start of statin administration. We used acetazolamide (1 g) as the vasodilator. The region of interest was the middle cerebral artery territory on a 3-dimensional stereotaxic region of interest template.

Results

Statin administration did not significantly affect the regional cerebral blood flow at rest. Before statin treatment, the patients' vasoreactivity, determined by the triple-injection technetium 99m-ethylcysteinate dimer method, demonstrated delayed, poor, or near-normal response patterns. Statin treatment improved vasoreactivity in all patients. Their mean serum total cholesterol level before statin administration was 200 mg/dL (range 187-256 mg/dL). Statin treatment significantly reduced their mean serum total cholesterol to 180 mg/dL (range 128-220 mg/dL) (P < .01).

Conclusions

The clinically confirmed stroke protection activity exerted by statins may be attributable to improved cerebrovascular reactivity.

Key Words: Statin, vascular reactivity, stroke, single photon emission computed tomography

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1052-3057(07)00144-9

doi:10.1016/j.jstrokecerebrovasdis.2007.09.005

Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 1 , Pages 16-22, January 2008